Overview

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

Status:
Completed

Trial end date:
2003-11-01

Target enrollment:

Participant gender:

Summary

The primary aim of the study is to evaluate the effects of correction of anemia using erythropoietin on the progression of atherosclerosis and cardiac muscle thickening in patients with chronic kidney disease

Phase:

N/A

Details

Lead Sponsor:

Hospital Authority, Hong Kong

Collaborator:

The Hong Kong Society of Nephrology

Treatments:

Epoetin Alfa